Comparing Abilify vs Vraylar
| Abilify (aripiprazole) | Vraylar (cariprazine) |
|
|---|
| Abilify (aripiprazole) | Vraylar (cariprazine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Abilify is an antipsychotic used to treat schizophrenia, manic and mixed episodes associated with Bipolar disorder, Tourette's Disorder, irritability associated with Autistic disorder, or for the... View more |
Prescription only
Vraylar is an atypical antipsychotic that is effective for the treatment of schizophrenia and bipolar I disorder. Vraylar is usually well-tolerated and less likely than some other antipsychotics to... View more |
Related suggestions Bipolar Disorder
Major Depressive Disorder
Schizophrenia
|
|||||||||||||||
| More about Abilify (aripiprazole) | More about Vraylar (cariprazine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Abilify has an average rating of 6.1 out of 10 from a total of 1195 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
Vraylar has an average rating of 6.1 out of 10 from a total of 534 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Abilify side effects |
View all Vraylar side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Abilify prices |
View all Vraylar prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other aripiprazole brands include: Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio, Mezofy, Opipza |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
146 hours |
504 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 733 drugs are known to interact with Abilify:
|
A total of 579 drugs are known to interact with Vraylar:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 15, 2002 |
September 17, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.